Life Sciences Voice is the leading resource for life sciences executives to get crucial insights,
explore the latest innovations, and learn about industry.

https://lifescivoice.com/

Life Sciences Voice

Articles 46
Views 2.6K
Followers 0

News | News

News | News

China: Emergency use approval granted to CanSino’s inhaled vaccine for Covid-19 - LifeSci Voice

The newly developed Covid vaccine by China’s CanSino Biologics Inc has been given the green light by the nation’s drug regulating authority to be used as a booster in emergency cases.  In a filing on Sunday, CanSino stated that their inhaled form

    News | News

    Guardant and Merck KGaA collaborate for cancer solution - LifeSci Voice

    In order to strengthen the development of precision oncology treatments, Guardant Health has partnered with Merck KGaA. The two companies have a history of a partnership, extending back to 2017, for the purpose of developing a liquid biopsy panel which wo

      News | News

      Boehringer Ingelheim receives its first dermatology approval from FDA - LifeSci Voice

      Boehringer Ingelheim has received its first dermatology approval from FDA, becoming the first company to do so for the treatment of generalised pustular psoriasis. Boehringer Ingelheim’s (BI) drug Spevigo has recently gained FDA approval for treatment o

        News | News

        European Commission Approved Bavarian Nordic’s Smallpox Vaccine

        European Commission (EC) has approved Imvanex, the smallpox vaccine from Bavarian Nordic. The drug can also be used against monkeypox.

          News | News

          Novratis and BeiGene’s PD-1 drug falls victim to FDA approval delay - LifeSci Voice

          The FDA has delayed the approval decision for Novratis and BeiGene’s tislelizumab. The inspections were supposed to take place in China.

            News | News

            Alternative therapy based S100A9 Protein best insulin dependent patients

            Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics.

              News | News

              FDA authorizes Novavax's Covid Vaccine - LifeSci Voice

              FDA authorized Novavax vaccine for adult, and this emergency use authorization is mainly to avoid COVID-19 in adults over the age of 18.

                News | News

                Akanda to Supply Cannabis to Tetra Bio-Pharma for FDA trials of QIXLEEF

                Akanda to Supply Cannabis to Tetra Bio-Pharma which is to be used in a vaporizer for commercialization of the company’s drug QIXLEEFTM

                  News | News

                  Moderna to open mRNA vaccine research and manufacturing Center in UK

                  Moderna has unveiled its plans to set up an Innovation and Technology Center focusing on the development of mRNA vaccines.

                    News | News

                    End Drug Shortages Alliance welcomes new member in Zydus Pharmaceuticals (USA) Inc - LifeSci Voice

                    Zydus Pharmaceuticals joined a union of diverse participants to address the issue of drug shortages in the US, the company announced. This new alliance is called the End Drug Shortages Alliance, which offers a platform for the key stakeholders to strategi

                      News | News

                      Kyowa Kirin Could Sell $1B in Assets as it Advances PI3K inhibitor

                      Japanese pharmaceutical company Kyowa Kirin is looking to sell assets worth $1B. According to reports, Kyowa Kirin could possibly be selling off some of its assets in the international market.

                        News | News

                        Pfizer invests $95 million in vaccine firm Valneva - LifeSci Voice

                        Pfizer has agreed to invest €90.5M or $95.6M in Valneva’s to back in support of the late-phase development of a vaccine for Lyme disease.

                          News | News

                          Heart Failure Drug Cytokinetics delayed FDA seeks more time to Review

                          The Food and Drug Administration requires more time to study Cytokinetics’ Omecamtiv mecarbil following analysis of some additional data.

                            News | News

                            Hansa gets NICE positive opinion for Idefirix in Kidney Transplant Patients

                            Hansa gets a positive opinion from NICE for Idefirix, becomes the first drug cleared NHS use in a group of kidney transplant patients.

                              News | News

                              Iktos and Zealand Agreement to Develop AI Peptide Drug Design

                              Iktos partnership with Zealand Pharma to develop predictive and generative artificial intelligence technologies for a peptide drug design.

                                News | News

                                FDA Approved Merck Pneumococcal Vaccine For Children - LifeSci Voice

                                US FDA has approved Merck’s pneumococcal 15-valent conjugate vaccine called Vaxneuvance for children between the age of 6 weeks and 17 years.

                                  News | News

                                  U.S. increasing distribution of monkey pox vaccine to contain the spread - LifeSci Voice

                                  The U.S. government is sending thousands of vaccines to states in the following months in an effort to hamper the spread of monkeypox.

                                    News | News

                                    Gensenta sold to Eczacıbaşı in $135 million deal - LifeSci Voice

                                    Amgen will continue its operations in Turkey, serving the region’s patients. Amgen has sold its majority stake in Gensenta, the oldest Turkish pharmaceutical company for $135 million in an agreement with the Eczacıbaşı Group. Eczacıbaşı has acquir

                                      News | News

                                      Brii Bio acquires Vir’s antibody rights for Hepatitis B in Greater China

                                      Brii Bio has acquired Vir’s antibody rights for Greater China two years after exercising first option. Brii Bio acquired rights marketing.

                                        News | News

                                        Astellas and Sutro Agreement to develop Immunostimulatory ADCs

                                        Sutro Biopharma and Astellas Pharma partnership and licensing agreement for the purpose of developing new iADCs (immunostimulatorya).

                                          News | News

                                          Steering Pharma’s Future: An Interview with Atria's Prakash Pothamsetti

                                          Artificial intelligence and big data are accelerating the speed at which pharma companies are transforming patient care and drug development.

                                            News | News

                                            How Data Science & AI Are Impacting the Patient Experience

                                            Artificial intelligence applications in healthcare have the power to produce enhancements of efficiency that are currently unimaginable.

                                              News | News

                                              Pfizer signs agreement to acquire Bio Pharma Firm GBT for $5.4bn

                                              Pfizer signed a conclusive agreement which entitles the company to all of Global Blood Therapeutics’ (GBT) outstanding shares.

                                                News | News

                                                Flynn Pharma and Pfizer fined 70M Pounds Price Jump On Epilepsy Drug

                                                Flynn Pharma and Pfizer has reached a verdict in terms of a fine. The two companies are to pay a collective fine of £70M, or $80.61M.

                                                  News | News

                                                  Flynn Pharma and Pfizer fined 70M Pounds Price Jump On Epilepsy Drug

                                                  Flynn Pharma and Pfizer has reached a verdict in terms of a fine. The two companies are to pay a collective fine of £70M, or $80.61M.

                                                    News | News

                                                    Human To Dog Monkey Pox Transmission 1st Suspected Case

                                                    First suspected case of monkey pox transmission from human to pet. According to a report in The Lancet dog diagnosed with monkey pox after its owners, who had monkey pox, shared the bed with him in France.

                                                      News | News

                                                      Human To Dog Monkey Pox Transmission 1st Suspected Case

                                                      First suspected case of monkey pox transmission from human to pet. According to a report in The Lancet dog diagnosed with monkey pox after its owners, who had monkey pox, shared the bed with him in France.

                                                        News | News

                                                        Lyme disease vaccine by Valneva up for final stage clinical trials - LifeSci Voice

                                                        Lyme disease vaccine was announced by Valneva and Pfizer and VLA15 only vaccine of its kind that progressed to the clinical stage.

                                                          News | News

                                                          Pfizer Claims it's RSV vaccine protects severe illness in Older Adults

                                                          Pfizer’s claims it's respiratory virus (RSV) vaccine was almost 86% effective in the prevention of serious illness.

                                                            News | News

                                                            Sanofi Gets FDA approval for Xenpozyme drug to Treat ASD

                                                            Acid Sphingomyelinase Disease (ASD) is a rare genetic disease that occurs when the body does not have the necessary enzyme.

                                                              News | News

                                                              Moderna sues BioNTech and Pfizer over mRNA Covid-19 vaccine patent - LifeSci Voice

                                                              According to Moderna, Comirnaty, the COVID-19 vaccine by BioNTech and Pfizer is in violation of the patents filed by Moderna between 2010 and 2016 that relate to mRNA technology founded by Moderna.

                                                                News | News

                                                                Aerie Pharmaceuticals to be acquired by Alcon - LifeSci Voice

                                                                Pharmaceutical companies Aerie and Alcon have announced that they have joined hands in merger agreement and Aerie will be acquired by Alcon.

                                                                  News | News

                                                                  FDA Accepts Biogen's ALS Therapy Tofersen For Review - LifeSci Voice

                                                                  Ionis announces that FDA accepts New Drug Application and grants Priority Review of Tofersen for a rare, genetic form of ALS.

                                                                    News | News

                                                                    HBC enters a global innovation alliance with Catalent to develop delayed-release softgel capsules - LifeSci Voice

                                                                    A Norway-based biotech firm, Hofseth BioCare ASA (HBC), that manufactures high-quality pharmaceuticals ingredients and complete products

                                                                      News | News

                                                                      Cerecor’s Covid-19 antibody treatment will get fast-track treatment from FDA - LifeSci Voice

                                                                      Cerecor, a complete human monoclonal antibody CERC-002, has received timely approval by the U.S. Food and Drug Administration (FDA)

                                                                        News | News

                                                                        Incyte agrees to pay $12.6M to settle kickback allegations - LifeSci Voice

                                                                        A Delaware-based pharmaceutical firm was accused of breaching the Federal False Claim Act by paying rebates and has decided

                                                                          News | News

                                                                          Sanofi accused of widespread employee email deletion tied to its 2019 recall of Zantac - LifeSci Voice

                                                                          Following FDA investigations on a contaminant suspected of causing cancer, Zantac, a renowned medication for acid reflux

                                                                            News | News

                                                                            Japan-based Nipro Pharma Packaging acquires Croatian manufacturer Piramida - LifeSci Voice

                                                                            Nipro, a Japanese pharmaceutical packaging firm, has purchased the acquisition of Piramida, a Croatian glass Pharmaceutical packaging manufacturer.

                                                                              News | News

                                                                              Incyte agrees to pay $12.6M to settle kickback allegations - LifeSci Voice

                                                                              A Delaware-based pharmaceutical firm was accused of breaching the Federal False Claim Act by paying rebates and has decided

                                                                                News | News

                                                                                Pfizer looks to build on its infectious disease expertise with Amplyx acquisition - LifeSci Voice

                                                                                Pfizer today has announced the acquisition of Amplyx Pharmaceuticals, a private firm focusing on the production of drugs for crippling

                                                                                  News | News

                                                                                  Potentially tough road for BMS as immuno-oncology pricing war looms - LifeSci Voice

                                                                                  The PD-1/L1 ( Programmed Death-1/Ligand 1) market that is already saturated is likely to become even more competitive

                                                                                    News | News

                                                                                    Israel is examining Covid-19 vaccine related cases of myocarditis - LifeSci Voice

                                                                                    Israel’s Ministry of Health is investigating cases related to myocarditis (inflammation of the heart’s muscle),

                                                                                      News | News

                                                                                      Japan-based Nipro Pharma Packaging acquires Croatian manufacturer Piramida - LifeSci Voice

                                                                                      Nipro, a Japanese pharmaceutical packaging firm, has purchased the acquisition of Piramida, a Croatian glass Pharmaceutical packaging manufacturer.

                                                                                        News | News

                                                                                        Most life sciences executives say digital delivery of drugs is the future of health - LifeSci Voice

                                                                                        The world’s leading connectivity and provider of electronic solutions, Molex and, its medical device distribution subsidiary, Phillips-Mediaize,

                                                                                          News | News

                                                                                          AI in Healthcare: How It's Changing the Industry — Lifesci Voice

                                                                                          Applications of AI in the Healthcare Industry AI in If you're interested in the potential applications of artificial intelligence AI in healthcare industry , you may want to take a look at this industry landscape. This report provides an overview of o